Patents by Inventor YiFang Wang

YiFang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12258394
    Abstract: Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a humanized antibody, and a pharmaceutical composition comprising said IL-5 antibody and said antigen binding fragment thereof, as well as the use of the pharmaceutical composition as a drug.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: March 25, 2025
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Hua Ying, Jinping Shi, Yifang Wang, Qiyue Hu, Hu Ge, Weikang Tao
  • Publication number: 20250034690
    Abstract: A device is for surface strengthening of a metal plate based ultrasonic vibration is provided. The device includes an ultrasonic vibration tool holder and a cutting tool. The ultrasonic vibration tool holder is internally provided with an ultrasonic transducer and an ultrasonic booster; the ultrasonic transducer is configured to transmit vibration to the ultrasonic booster, the ultrasonic booster is configured to drive longitudinal torsion vibration of the cutting tool; an end of the ultrasonic booster facing towards the cutting tool is provided with an adjustment assembly configured for adjusting a longitudinal torsion angle and a rotation speed. Since the device includes the adjustment assembly, the longitudinal torsion angle and the rotation speed of the device can be adjusted according to different processing requirements, so as to perform ultrasonic vibration extrusion strengthening on surfaces of titanium alloy plates and improve surface integrity including microhardness and residual stress.
    Type: Application
    Filed: January 10, 2024
    Publication date: January 30, 2025
    Inventors: Yunhe Zou, Qibing Wang, Shufeng Tang, Shijie Guo, Jianxin Wu, Haitang Cen, Jianguo Qin, Yifang Wang, Xiaojuan Song, Huaqiang Li, Yuezheng Lan, Xiaodong He, Wenzhi Zhang, Xiaowen Song, He Lyu, Xuewei Zhang, Yongga A
  • Patent number: 12209301
    Abstract: A device is for surface strengthening of a metal plate based ultrasonic vibration. The device includes an ultrasonic vibration tool holder and a cutting tool. The ultrasonic vibration tool holder is internally provided with an ultrasonic transducer and an ultrasonic booster; the ultrasonic transducer is configured to transmit vibration to the ultrasonic booster, the ultrasonic booster is configured to drive longitudinal torsion vibration of the cutting tool; an end of the ultrasonic booster facing towards the cutting tool is provided with an adjustment assembly configured for adjusting a longitudinal torsion angle and a rotation speed. Since the device includes the adjustment assembly, the longitudinal torsion angle and the rotation speed of the device can be adjusted according to different processing requirements, so as to perform ultrasonic vibration extrusion strengthening on surfaces of titanium alloy plates and improve surface integrity including microhardness and residual stress.
    Type: Grant
    Filed: January 10, 2024
    Date of Patent: January 28, 2025
    Assignees: Inner Mongolia University of Technology, China Jiliang University
    Inventors: Yunhe Zou, Qibing Wang, Shufeng Tang, Shijie Guo, Jianxin Wu, Haitang Cen, Jianguo Qin, Yifang Wang, Xiaojuan Song, Huaqiang Li, Yuezheng Lan, Xiaodong He, Wenzhi Zhang, Xiaowen Song, He Lyu, Xuewei Zhang, Yongga A
  • Patent number: 12202891
    Abstract: Disclosed are an antibody capable of binding to thymic stromal lymphopoietin and the use thereof. Disclosed are an anti-TSLP antibody, comprising a murine antibody, chimeric antibody and humanized antibody of the light chain and heavy chain variable regions of the anti-TSLP antibody and antigen-binding fragments thereof, or a pharmaceutically acceptable salt or solvent compound thereof, and the use thereof as a medicament for treating asthma, especially the use thereof in the preparation of a drug for treating TSLP-positive diseases or conditions.
    Type: Grant
    Filed: March 15, 2024
    Date of Patent: January 21, 2025
    Inventors: Jinping Shi, Hua Ying, Tingting Li, Yifang Wang, Guimei Yang, Hu Ge, Weikang Tao
  • Publication number: 20240254215
    Abstract: Disclosed are an antibody capable of binding to thymic stromal lymphopoietin and the use thereof. Disclosed are an anti-TSLP antibody, comprising a murine antibody, chimeric antibody and humanized antibody of the light chain and heavy chain variable regions of the anti-TSLP antibody and antigen-binding fragments thereof, or a pharmaceutically acceptable salt or solvent compound thereof, and the use thereof as a medicament for treating asthma, especially the use thereof in the preparation of a drug for treating TSLP-positive diseases or conditions.
    Type: Application
    Filed: March 15, 2024
    Publication date: August 1, 2024
    Inventors: Jinping SHI, Hua YING, Tingting LI, Yifang WANG, Guimei YANG, Hu GE, Weikang TAO
  • Publication number: 20240208144
    Abstract: The present invention relates to a method for producing an at least partially coated object and to an at least partially coated object obtained by the method. The method comprises bringing the object completely or partly into contact with a treating agent; leaving the object at 10° C.-30° C. and 100 mbar-800 mbar for 3-10 minutes; and heat-treating the object at a temperature of 70° C.-90° C.
    Type: Application
    Filed: April 25, 2022
    Publication date: June 27, 2024
    Inventors: Fei LIN, Yifang WANG, Jie QIAO, Chenxi ZHANG
  • Publication number: 20230152956
    Abstract: The present application discloses a wallpaper display control method and apparatus and an electronic device, which belong to the technical field of electronic devices. The method includes: receiving a first input performed by a user, where the first input is used to trigger lighting of a screen of an electronic device; and in response to the first input, control an object layer image of a wallpaper image of the screen of the electronic device to execute a first display animation based on a first animation parameter, and control a background layer image of the wallpaper image to execute a second display animation based on a second animation parameter, where the first animation parameter and the second animation parameter are different.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 18, 2023
    Inventor: Yifang WANG
  • Publication number: 20220356239
    Abstract: Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a humanized antibody, and a pharmaceutical composition comprising said IL-5 antibody and said antigen binding fragment thereof, as well as the use of the pharmaceutical composition as a drug.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 10, 2022
    Inventors: Hua Ying, Jinping Shi, Yifang Wang, Qiyue Hu, Hu Ge, Weikang Tao
  • Publication number: 20220340654
    Abstract: Disclosed are an antibody capable of binding to thymic stromal lymphopoietin and the use thereof. Disclosed are an anti-TSLP antibody, comprising a murine antibody, chimeric antibody and humanized antibody of the light chain and heavy chain variable regions of the anti-TSLP antibody and antigen-binding fragments thereof, or a pharmaceutically acceptable salt or solvent compound thereof, and the use thereof as a medicament for treating asthma, especially the use thereof in the preparation of a drug for treating TSLP-positive diseases or conditions.
    Type: Application
    Filed: June 3, 2020
    Publication date: October 27, 2022
    Inventors: Jinping SHI, Hua YING, Tingting LI, Yifang WANG, Guimei YANG, Hu GE, Weikang TAO
  • Patent number: 11365247
    Abstract: Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a humanized antibody, and a pharmaceutical composition comprising said IL-5 antibody and said antigen binding fragment thereof, as well as the use of the pharmaceutical composition as a drug.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: June 21, 2022
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Hua Ying, Jinping Shi, Yifang Wang, Qiyue Hu, Hu Ge, Weikang Tao
  • Publication number: 20200369774
    Abstract: Provided in the present invention are an IL-6R antibody and antigen-binding fragment thereof. The IL-6R antibody is an alpaca-derived antibody, chimeric antibody and humanized antibody. Also provided in the present invention is the use of the antibody in the preparation of a drug for treating IL-6-related diseases.
    Type: Application
    Filed: September 12, 2018
    Publication date: November 26, 2020
    Applicants: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Hua Ying, Houcong Jin, Qiyue Hu, Hu Ge, Yifang Wang, Weikang Tao
  • Patent number: 10449250
    Abstract: Provided is a humanized antibody and chimeric antibody that specifically binds human sclerostin. The antibodies can be used for treating human bone metabolism related diseases such as osteoporosis (OP).
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: October 22, 2019
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Jiajian Liu, Yayuan Fu, Haoying Zhang, Yifang Wang, Zhen Zhang, Ling Zhang, Dongbing Cui, Lianshan Zhang, Weikang Tao
  • Publication number: 20180099046
    Abstract: Provided is a humanized antibody and chimeric antibody that specifically binds human sclerostin. The antibodies can be used for treating human bone metabolism related diseases such as osteoporosis (OP).
    Type: Application
    Filed: February 16, 2016
    Publication date: April 12, 2018
    Applicants: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Jiajian LIU, Yayuan FU, Haoying ZHANG, Yifang WANG, Zhen ZHANG, Ling ZHANG, Dongbing CUI, Lianshan ZHANG, Weikang TAO
  • Patent number: 7273932
    Abstract: The invention relates to antisense oligonucleotides, in particular to antisense oligonucleotides to receptor genes, and the use of such oligonucleotides to regulate reproductive function and as chemopreventive or as a chemotherapeutic for various cancers, especially ovarian cancers. The invention also provides a method for preventing estrogen synthesis, a function of developing ovarian follicles, a therapeutic consideration for the prevention and treatment of some cancers of the breast, endometrium, ovary and cervix and of some endometriosis. The invention also relates to pharmaceutical compositions containing antisense oligonucleotides (ODNs, having 8 to 60 nucleotides) that act by binding to intracellular molecular targets. Optionally, for efficient delivery to a target DNA, RNA or protein, the ODNs may be covalently linked to a carrier moiety, which facilitates delivery of the ODN to the cytosol.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: September 25, 2007
    Assignee: The University of Cincinnati
    Inventors: Andrew R. LaBarbera, YiFang Wang, ChangHong Zhu